UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Dillon & Associates Inc.

Dillon & Associates Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,167 shares of the healthcare conglomerate’s stock after selling 38 shares during the period. Dillon & Associates Inc.’s holdings in UnitedHealth Group were worth $591,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Wallace Capital Management Inc. grew its holdings in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after acquiring an additional 19 shares during the period. Western Pacific Wealth Management LP grew its holdings in UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares during the period. MCF Advisors LLC grew its holdings in UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after acquiring an additional 20 shares during the period. Axiom Financial Strategies LLC grew its holdings in UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after acquiring an additional 20 shares during the period. Finally, Richwood Investment Advisors LLC grew its holdings in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after acquiring an additional 20 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $517.72 on Monday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $510.19 and its two-hundred day moving average is $546.71. The company has a market cap of $473.57 billion, a P/E ratio of 33.40, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.